Literature DB >> 14221786

PERSPECTIVES IN CANCER CHEMOTHERAPY: THERAPEUTIC DESIGN.

H E SKIPPER.   

Abstract

Keywords:  ANTINEOPLASTIC AGENTS; DRUG THERAPY; LEUKEMIA L1210; NEOPLASM THERAPY; PHARMACOLOGY; RESEARCH

Mesh：

Substances：

Year:  1964        PMID： 14221786

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  6 in total

1.  Role of the host in the variable chemotherapeutic response of advanced Ridgway osteogenic sarcoma.

Authors:  J A Nelson; J A Hokanson; V K Jenkins
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

2.  Therapies with diverse mechanisms of action kill cells by a similar exponential process in advanced cancers.

Authors:  Krastan B Blagoev; Julia Wilkerson; Wilfred D Stein; James Yang; Susan E Bates; Tito Fojo
Journal:  Cancer Res       Date:  2014-09-01       Impact factor: 12.701

3.  Studies of cellular proliferation in human leukemia. I. Estimation of growth rates of leukemic and normal hematopoietic cells in two adults with acute leukemia given single injections of tritiated thymidine.

Authors:  B Clarkson; T Ohkita; K Ota; J Fried
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

Review 4.  Strategies to improve outcomes of autologous hematopoietic cell transplant in lymphoma.

Authors:  Parastoo B Dahi; Hillard M Lazarus; Craig S Sauter; Sergio A Giralt
Journal:  Bone Marrow Transplant       Date:  2018-11-02       Impact factor: 5.174

5.  Prediction of Treatment Response for Combined Chemo- and Radiation Therapy for Non-Small Cell Lung Cancer Patients Using a Bio-Mathematical Model.

Authors:  Changran Geng; Harald Paganetti; Clemens Grassberger
Journal:  Sci Rep       Date:  2017-10-19       Impact factor: 4.379

6.  A Perspective on Expanding Our Understanding of Cancer Treatments by Integrating Approaches from the Biological and Physical Sciences.

Authors:  Emma J Fong; Carly Strelez; Shannon M Mumenthaler
Journal:  SLAS Discov       Date:  2020-04-16       Impact factor: 3.341
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.